PDS Biotechnology Corporation ( PDSB) - Key Metrics
PDSB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$50.17 | -$50.17 |
| 2026Q1 | $0 | -$0.13 | -$78.77 | -$78.77 |
| 2025Q4 | $0 | -$0.16 | -$0.08 | -$0.08 |
| 2025Q3 | $0 | -$0.19 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$0.21 | -$0.20 | -$0.20 |
PDSB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.22 |
| 2026Q1 | 0% | -1.16 |
| 2025Q4 | 0% | -1.37 |
| 2025Q3 | 0% | -1.33 |
| 2025Q2 | 0% | -1.58 |
PDSB
Price: $0.21
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 392200
Market Capitalization: 12.9 million